Applied Genetic Technologies (AGTC) PT Lifted to $42 at BMO Capital on 'Transformational' Deal with Biogen (BIIB)
Tweet Send to a Friend
BMO Capital analyst Jim Birchenough raised his price target on Outperform-rated Applied Genetic Technologies Corp. (NASDAQ: AGTC) to $42.00 (from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
